Sherbrooke Park Advisers »

Theravance Biopharma shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $280k 35k 8.06
2024-06-30 $445k 53k 8.48

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Oasis Management
Camber Capital Management
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Dimensional Fund Advisors
Nuveen Asset Management

View all funds holding Theravance Biopharma